Saturday, November 08, 2025




In Detail Full day, Saturday, November 08, 2025, Timezone: America/Chicago


<![CDATA[Younger Age at Glomerular Disease Diagnosis Linked to Greater Lifetime Risk Despite Similar Progression Rates]]> / HCP Live

hcplive -

#healthcare #publichealth

4 months / hcplive

4 months / hcplive


Saturday, November 8, 2025, 8:21 pm / permalink 15810 / 3 stories in 4 months


Pfizer poised to buy Metsera in $10 bn deal after bidding war / Medical Express

medicalxpress - Pfizer was poised to seal a takeover of Metsera on Saturday after its improved offer won over the biotechnology startup's board and Danish challenger Novo Nordisk called a halt to a back-and-forth bidding war.

#obesity #healthcare #pharmaceuticals #novonordisk #weightloss #pfizer #biotech #mergersandacquisitions #corporatetakeover #drugdevelopment


Saturday, November 8, 2025, 3:21 pm / permalink 15805 / 2 stories in 4 months


Intensive blood pressure lowering could benefit almost all adults with hypertensive chronic kidney disease / Medical Express

medicalxpress - An analysis of the Systolic Blood Pressure Intervention Trial (SPRINT) indicates that nearly all adults with chronic kidney disease (CKD) would have benefits that outweigh the harm from a systolic blood pressure target of

#healthcare #publichealth

4 months / hcplive


Saturday, November 8, 2025, 2:22 pm / permalink 15802 / 2 stories in 4 months


#AHA25: Amgen’s cholesterol drug cuts first-time cardiovascular events by a quarter / Endpoints

Elizabeth Cairns / endpoints - Amgen on Saturday said its cholesterol-lowering drug Repatha cut cardiovascular events by 25% when added on top of standard therapy in high-risk patients who have never had a heart attack or stroke. Repatha is already ...

#healthcare #pharmaceuticals #publichealth

4 months / hcplive

4 months / hcplive

4 months / hcplive

4 months / hcplive

4 months / hcplive


Saturday, November 8, 2025, 9:21 am / permalink 15793 / 13 stories in 4 months


FDA approves J&J’s Darzalex for smoldering multiple myeloma / Endpoints

Lei Lei Wu / endpoints - The FDA on Thursday approved Johnson & Johnson’s Darzalex injection for high-risk smoldering multiple myeloma, a condition in which people have abnormal cells that could turn into myeloma but don’t have ...

#healthcare #pharmaceuticals #publichealth

4 months / targetedonc


Saturday, November 8, 2025, 12:21 am / permalink 15786 / 3 stories in 4 months


CMS unveils new Medicaid drug payment model / Endpoints

Max Bayer / endpoints - CMS plans to launch a new drug payment model for state Medicaid programs, the first of potentially multiple pricing models under President Donald Trump's "most favored nation" push that the pharma industry has been closely ...

#healthcare #pharmaceuticals #drugpricing #publichealth #governmentpolicy


Saturday, November 8, 2025, 12:21 am / permalink 15785 / 3 stories in 4 months


Patient in Intellia CRISPR trial dies after being hospitalized with liver injury / Endpoints

Ryan Cross / endpoints - A man in his early 80s who was recently hospitalized with liver injury, a few weeks after receiving an experimental gene editing therapy, died on Wednesday ...

#healthcare #pharmaceuticals #publichealth


Saturday, November 8, 2025, 12:21 am / permalink 15784 / 2 stories in 4 months


DNA pioneer James Watson dies at 97 / BBC

bbc - The Nobel Prize winner felt ostracised by the scientific community over his comments on race and intelligence.

#none


Saturday, November 8, 2025, 12:21 am / permalink 15783 / 3 stories in 4 months


StackHealth Time Machine




Outgoing Stories


Judge orders Leapfrog to remove safety grades for five Florida hospitals 3 stories in 21.1 hours

Daily multivitamin slows epigenetic aging in randomized COSMOS analysis 4 stories in 40.1 hours

Engineered CAR‑T cells secreting VEGF‑neutralizing scFvs boost solid‑tumor activity 6 stories in 54.2 hours

White House briefing triggered rapid drops in acetaminophen use in ERs 2 stories in 58.1 hours

MUSC Health buys large South Carolina multispecialty practice for $111M 4 stories in 58.2 hours

Eli Lilly launches Employer Connect to broaden GLP‑1 coverage 16 stories in 83.2 hours

Analysis finds small patient group drives majority of admissions and costs 2 stories in 83.2 hours

Springing forward worsens sleep and sparks health complaints 8 stories in 87.2 hours

Cancer Grand Challenges awards five teams bold funding for cancer research 67 stories in 94.2 hours

Belzutifan combinations highlighted at ASCO GU improve RCC outcomes 3 stories in 96.2 hours


More StackHealth


Bluesky:



NorthFeed Inc.

Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.